Tower Research Capital LLC (Trc) Virpax Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.24 - $0.82 $23 - $80	98 Added 1.58%	6,318 $2,000
Q3 2023 Nov 14, 2023	BUY	$0.76 - $1.1 $598 - $865	787 Added 14.49%	6,220 $4,000
Q2 2023 Aug 14, 2023	SELL	$0.64 - $1.09 $19 - $32	-30 Reduced 0.55%	5,433 $5,000
Q1 2023 May 09, 2023	BUY	$0.67 - $1.15 $223 - $382	333 Added 6.49%	5,463 $4,000
Q4 2022 Feb 10, 2023	BUY	$0.62 - $12.0 $399 - $7,728	644 Added 14.36%	5,130 $3,000
Q3 2022 Nov 10, 2022	BUY	$1.15 - $11.9 $2,166 - $22,419	1,884 Added 72.41%	4,486 $5,000
Q2 2022 Aug 15, 2022	BUY	$1.22 - $2.25 $3,174 - $5,854	2,602 New	2,602 $4,000
Q1 2022 May 12, 2022	SELL	$1.86 - $3.61 $1,195 - $2,321	-643 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.19 - $4.89 $2,051 - $3,144	643 New	643 $2,000

Ticker VRPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,714,600
Market Cap $7.97M
Description
Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical no...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.